Compagnie Lombard Odier SCmA’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$312K Buy
330,000
+220,000
+200% +$208K ﹤0.01% 207
2025
Q1
$50.7K Hold
110,000
﹤0.01% 352
2024
Q4
$81.2K Buy
110,000
+10,000
+10% +$7.39K ﹤0.01% 305
2024
Q3
$157K Buy
100,000
+6,000
+6% +$9.42K ﹤0.01% 261
2024
Q2
$158K Hold
94,000
﹤0.01% 261
2024
Q1
$226K Hold
94,000
﹤0.01% 249
2023
Q4
$144K Hold
94,000
﹤0.01% 323
2023
Q3
$102K Hold
94,000
﹤0.01% 352
2023
Q2
$215K Hold
94,000
0.01% 254
2023
Q1
$228K Sell
94,000
-4,000
-4% -$9.72K 0.01% 267
2022
Q4
$187K Hold
98,000
0.01% 303
2022
Q3
$235K Hold
98,000
0.01% 279
2022
Q2
$182K Buy
98,000
+94,000
+2,350% +$175K ﹤0.01% 303
2022
Q1
$8K Hold
4,000
﹤0.01% 552
2021
Q4
$16K Hold
4,000
﹤0.01% 597
2021
Q3
$19K Hold
4,000
﹤0.01% 562
2021
Q2
$18K Hold
4,000
﹤0.01% 558
2021
Q1
$23K Hold
4,000
﹤0.01% 560
2020
Q4
$14K Hold
4,000
﹤0.01% 519
2020
Q3
$6K Hold
4,000
﹤0.01% 477
2020
Q2
$8K Hold
4,000
﹤0.01% 475
2020
Q1
$8K Hold
4,000
﹤0.01% 441
2019
Q4
$17K Sell
4,000
-1,500
-27% -$6.38K ﹤0.01% 416
2019
Q3
$17K Hold
5,500
﹤0.01% 422
2019
Q2
$34K Hold
5,500
﹤0.01% 383
2019
Q1
$30K Hold
5,500
﹤0.01% 431
2018
Q4
$37K Hold
5,500
﹤0.01% 399
2018
Q3
$59K Hold
5,500
﹤0.01% 399
2018
Q2
$66K Hold
5,500
﹤0.01% 398
2018
Q1
$47K Sell
5,500
-2,500
-31% -$21.4K ﹤0.01% 449
2017
Q4
$80K Buy
8,000
+6,200
+344% +$62K ﹤0.01% 489
2017
Q3
$22K Hold
1,800
﹤0.01% 585
2017
Q2
$30K Sell
1,800
-700
-28% -$11.7K ﹤0.01% 572
2017
Q1
$36K Buy
2,500
+1,800
+257% +$25.9K ﹤0.01% 572
2016
Q4
$10K Hold
700
﹤0.01% 747
2016
Q3
$13K Hold
700
﹤0.01% 819
2016
Q2
$10K Sell
700
-3,871
-85% -$55.3K ﹤0.01% 827
2016
Q1
$55K Sell
4,571
-3,000
-40% -$36.1K ﹤0.01% 699
2015
Q4
$101K Buy
+7,571
New +$101K ﹤0.01% 591
2015
Q2
Sell
-7,571
Closed -$50K 893
2015
Q1
$50K Hold
7,571
﹤0.01% 785
2014
Q4
$48K Buy
+7,571
New +$48K ﹤0.01% 635